Skip to content

Zhen Wang

4 papers in the library · 1 citation · publishing 2018-2025

Papers

Sort Most recent Most cited

Local field potential changes during euthanasia may parallel with near death experience.

Scientific Reports April 3, 2025 Julieta Trejo, Kaitlin M Killian, Zhen Wang et al. 1 citation

A global experience that every human life meets is death. For several decades, individuals have reported their unique encounters with near-death experience (NDE), which has raised many unanswered questions. In the present experiment, we utilize continuous local field potential (LFP) during the euthanasia process to show the dynamic changes of frequency band power in four distinct regions of the...

Mindfulness-Based Cognitive Therapy for Unmedicated Obsessive-Compulsive Disorder: A Randomized Controlled Trial With 6-Month Follow-Up.

Frontiers in Psychiatry 2021 Tianran Zhang, Lu Lu, Fabrizio Didonna et al.

Background: This was the first randomized controlled trial (RCT) designed to compare the efficacy of mindfulness-based cognitive therapy (MBCT) on unmedicated obsessive-compulsive disorder with that of the first-line treatment for OCD (SSRIs) or a placebo, as well as to analyze the treatment acceptability and safety of MBCT. Methods: A total of 123 unmedicated OCD patients with mild to moderate...

Sub-anesthetic and anesthetic ketamine produce different long-lasting behavioral phenotypes (24 h post-treatment) via inducing different brain-derived neurotrophic factor (BDNF) expression level in the hippocampus.

Neurobiology of Learning and Memory December 5, 2019 Chunhui Wu, Yu Wang, Yang He et al.

Clinical and preclinical researches have shown that sub-anesthetic ketamine elicits sustained antidepressant effects for up to 1-2 weeks. Pharmacokinetics studies (t1/2 = 23 min) in mice showed no ketamine residue at 24 h after sub-anesthetic or anesthetic ketamine administration. Therefore, this study aims to reveal the mechanism underlying these different biological functions at 24 h after...

Essential roles of neuropeptide VGF regulated TrkB/mTOR/BICC1 signaling and phosphorylation of AMPA receptor subunit GluA1 in the rapid antidepressant-like actions of ketamine in mice.

Brain Research Bulletin October 2018 Mengxin Shen, Dan Lv, Xu Liu et al.

Previous studies have suggested that rapid reductions in depression-like behaviors are observed in response to sub-anesthetic-doses of ketamine, an N-methyl-d-aspartate receptor (NMDAR) antagonist. Neuropeptide VGF (non-acronymic) is a critical effector of depression-like behaviors and is thought to be involved in the antidepressant actions of ketamine that have been demonstrated. However, the...